THE ROLE OF TRANSFORMING GROWTH FACTOR BETA 1 AND PLATELETS IN THE DEVELOPMENT OF RESISTANCE OF ACUTE LEUKEMIA TO TREATMENT

EHA Library, Vira Barilka, 4161416

ANALYSIS OF CLINICAL AND LABORATORY CHARACTERISTICS OF ALL WITH ATYPICAL BCR::ABL1 FUSION GENES

EHA Library, Yanbo Nie, 4161454

SYSTEMATIC FLOW CYTOMETRY ANALYSIS REFINES THE DETECTION OF CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Lena Veauvy, 4161453

OUTCOMES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER INOTUZUMAB OZOGAMICIN TREATMENT FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITHOUT VOD/SOS

EHA Library, Weihua Zhai, 4161452

PROGNOSTIC FACTORS AND OUTCOMES OF ADULT PATIENTS WITH MIXED PHENOTYPE ACUTE LEUKEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Mirjana Cvetkovic, 4161451

ASSOCIATION OF FOXO3 (RS17069665) GENE POLYMORPHISM AND CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN EGYPT

EHA Library, Samar Elbahy, 4161450

SPATIOTEMPORAL DISTRIBUTION AND SOCIOECONOMIC DETERMINANTS OF REGIONAL DISPARITIES IN LYMPHOID LEUKEMIA MORTALITY AMONG CHILDREN AND ADOLESCENTS IN BRAZIL: AN ECOLOGICAL STUDY

EHA Library, Bárbara Sarni Sanches, 4161449

A QUALITY-ADJUSTED SURVIVAL ANALYSIS IN ADULT AND ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: COMPARING REDUCED-INTENSITY AND FULL-DOSE CHEMOTHERAPY REGIMENS

EHA Library, Fausto Alfredo Rios-Olais, 4161448

LABORATORY EVALUATION, CLINICAL FEATURES, AND PROGNOSTIC ANALYSIS OF ACUTE LEUKEMIA WITH TAF15::ZNF384 FUSION GENE

EHA Library, Zheng Wang, 4161447

FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS

EHA Library, Nikesh Shah, 4161446

OUTCOMES WITH PRETRANSPLANT BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH PTCY FOR B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Noah Merin, 4161445

THE INCIDENCE OF OBESITY AND METABOLIC SYNDROME DEVELOPMENT IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER COMPLETING TREATMENT

EHA Library, Adalet Meral Güneş, 4161444

EFFICACY IN CLEARING NGS-MRDAND SHORT-TERM PROGNOSIS OF 14-DAY VERSUS 28-DAY BLINATUMOMAB IN PEDIATRIC B-ALL

EHA Library, YingJin Zhang, 4161443

EFFICACY AND SAFETY OF INOTUZUMAB OZOGAMICIN IN ADULT CHINESE PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: PRIMARY RESULTS OF AN OPEN-LABEL, MULTI-CENTER PHASE 4 TRIAL.

EHA Library, Depei Wu, 4161441

18F-FDG PET/CT REVEALED A HIGHER INCIDENCE OF EXTRAMEDULLARY DISEASES IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ruifeng Hou, 4161440

IMPACT OF ADDITIONAL CHROMOSOME 9 ABNORMALITIES ON OUTCOMES IN BCR::ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA - A 10-YEAR NATIONWIDE REGISTRY STUDY

EHA Library, Wasithep Limvorapitak, 4161439

PROSPECTIVE ASSESSMENT OF BONE MINERAL DENSITY, BONE AND MINERAL MARKERS AND BODY COMPOSITION TRENDLINES FOLLOWING ACUTE LYMPHOBLASTIC LEUKAEMIA IN PAEDIATRICS

EHA Library, Adriana Balduzzi, 4161438

EFFICACY AND SAFETY OF BLINATUMOMAB IN NEWLY-DIAGNOSED PATIENTS WITH PH-POSITIVE/NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yinqiang Zhang, 4161437

THE RETROSPECTIVE, MULTICENTER COHORT STUDY OF CHIDAMIDE MAINTENANCE THERAPY WITH ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xu Chen, 4161436

EFFICACY AND SAFETY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CD19 CAR-T IN ADULTS WITH HIGH-RISK B-ALL: A PHASE II STUDY

EHA Library, Rongli Zhang, 4161435

EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN RELAPSED AND PERSISTENT MRD POSITIVE PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Xinwen Jiang, 4161434

TYROSINE KINASE INHIBITORS WITH BLINATUMOMAB VERSUS CHEMOTHERAPY IN PHILADELPHIA-POSITIVE ACUTE B-LYMPHOBLASTIC LEUKEMIA

EHA Library, Max Rieger, 4161433

INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN PEDIATRIC AND ADOLESCENT PATIENTS

EHA Library, Zuofei Chi, 4161432

SAFETY AND EFFICACY OF CHIDAMIDE AS MAINTENANCE THERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH T-ALL/T-LBL

EHA Library, Kuangfei Wang, 4161431

HAPLOIDENTICAL STEM CELLS TRANSPLANTATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS: A MULTICENTER, REAL-WORLD STUDY

EHA Library, Danya Shen, 4161430

ANALYSIS OF RISK FACTORS FOR SECONDARY PANCREATITIS FOLLOWING ASPARAGINASE RE-EXPOSURE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Xuedong Wu, 4161429

UTILITY OF MEASURABLE RESIDUAL DISEASE MONITORING DETECTED BY NGS USING IGH ASSAY AFTER FIRST AND SECOND CYCLE OF CHEMOTHERAPY IN ADULT B-LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A MULTICENTER STUDY.

EHA Library, Chantana Polprasert, 4161428

A GENOMIC PROFILE OF RESISTANT AND RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: A SINGLE CENTER ANALYSIS.

EHA Library, Anna Płotka, 4161427

EFFICACY OF 8 GRAY FLU-TBI BASED CONDITIONING IN ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE-LYMPHOBLASTIC LEUKEMIA.

EHA Library, Rohan Halder, 4161426

EXPERIENCE WITH BLINATUMOMAB IN PATIENTS WITH PH-NEGATIVE ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA WHO SHOW MINIMAL RESIDUAL DISEASE AT THE END OF INDUCTION THERAPY AS PART OF TREATMENT UNDER THE ALL-2016M PROTOCOL. A SINGLE CENTER EXPERIENCE.

EHA Library, Ekaterina Kotova, 4161425

LOW FIXED DOSE INOTUZUMAB IS EQUALLY EFFECTIVE SINGLE AGENT SALVAGE THERAPY IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Isha Gambhir, 4161424

MUTATIONAL ANALYSIS OF SOMATIC IKAROS MUTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Rim Frikha, 4161423

TRANSCRIPTOME DATA ANALYSIS OF 80 B ALL PATIENTS IN CHINA

EHA Library, Yuehui Lin, 4161422

TIME AND DOSE-DEPENDENT EFFECTS OF PERK INHIBITION IN A DUX4-R B- ACUTE LEUKEMIA CELL LINE

EHA Library, Mercilena Benjamin, 4161421

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Olena Zotova, 4161420

DRUG TRANSPORTER SIGNATURE IN CHILDHOOD ACUTE LEUKEMIA USING AN INTEGRATED APPROACH OF CELL SORTING AND MOLECULAR BIOLOGY: PRELIMINARY FINDINGS.

EHA Library, Alessandra Cianflone, 4161418

EVALUATION OF CONSISTENCY IN GENE MUTATION DETECTION BY DNA AND RNA IN PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Gang Xu, 4161401

FLT3 ALTERATIONS ARE FREQUENT IN ADULT PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND CORRELATE WITH HIGH EXPRESSION AND SPECIFIC GENETIC SUBSETS

EHA Library, Rossana Maffei, 4161403

THE SYNERGY OF HDACI CHIDAMIDE WITH CX-4945 ON THERAPEUTIC EFFICACY BY REPRESSING TCL1A TRANSCRIPTION IN HIGH-RISK B-ALL

EHA Library, huimin xiang, 4161404

MITOCHONDRIAL REGULATION IS DISTURBED IN THE BONE MARROW DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELLS OF PATIENTS WITH ACUTE LEUKEMIA.

EHA Library, Aleksandra Sadovskaya, 4161405

DYNAMIC GLYCOGEN METABOLISM IN ALL RECURRENCE: INTEGRATED CLINICAL-MOLECULAR INSIGHTS FROM A RETROSPECTIVE-PROSPECTIVE COHORT STUDY

EHA Library, Wenqiu Huang, 4161406

THE CIRCULATING BLOOD PROTEOME OF CHILDHOOD ACUTE LEUKEMIA

EHA Library, Maria Globisch, 4161407

A NOVEL SKP2 INHIBITOR TRIGGERS PYROPTOSIS IN PH+ ALL VIA DYSREGULATION OF GLYCEROPHOSPHOLIPID METABOLISM

EHA Library, Jinyi Liu, 4161408

IGJ IMMUNOSTAIN: A USEFUL TOOL FOR SCREENING OF PH POSITIVE AND PH-LIKE B-LYMPHOBLASTIC LEUKEMIA

EHA Library, Chaimae El Mahdaoui, 4161409

TARGETING THE CK2/IKAROS AXIS SENSITIZES IMATINIB ANTI-LEUKEMIA EFFICACY BY REPRESSING GLUT1 EXPRESSION AND GLYCOLYSIS IN PH+ ALL

EHA Library, Linyao Zhang, 4161410

AN EXTENDED FLOW CYTOMETRY PANEL AS A SCREENING TOOL FOR PH-LIKE ALL

EHA Library, Adrianna Cieloch, 4161411

NICLOSAMIDE SYNERGIZES WITH EPIRUBICIN TO OVERCOME DRUG RESISTANCE IN T-ALL CELLS

EHA Library, Fang-Liang Huang, 4161412

IMMUNOPHENOTYPIC AND GENETIC CORRELATIONS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A REAL-WORLD SETTING

EHA Library, Ana Paula de Azambuja, 4161413

PDGFA AND PDGFB DEFICIENCY IMPAIRS ACUTE LEUKEMIA PATIENTS' SERUM CAPABILITY TO SUSTAIN MULTIPOTENT MESENCHYMAL STROMAL CELLS

EHA Library, Nataliya Petinati, 4161414

SYNERGISTIC EFFECTS OF OLVEREMBATINIB (HQP1351) COMBINED WITH BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) AND BCL-2/BCL-XL INHIBITOR PELCITOCLAX (APG-1252) IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Bo Peng, 4161415

EPIDEMIOLOGICAL PROFILE OF ACUTE LEUKEMIA IN PEDIATRIC PATIENTS: SUBTYPES AND ABERRANT MARKERS IN 111 CASES FROM A HEMATOLOGY DEPARTMENT IN NORTHERN TUNISIA

EHA Library, Roua Hsasna, 4161419

COMBINING CYTOMORPHOLOGY AND FLUORESCENCE IN SITU HYBRIDIZATION TO DIAGNOSE NEW SUBTYPES OF PHILADELPHIA CHROMOSOME-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Dongge gao, 4161417

CIRCULATING TUMOUR DNA ANALYSIS IN FOLLICULAR LYMPHOMA TREATED WITH FIRST-LINE VENETOCLAX, LENALIDOMIDE AND OBINUTUZUMAB ON THE LEVERAGE TRIAL

EHA Library, Piers Blombery, 4159421

Takeaways & Closing

EHA Library, Faculty / Presenters, 4171852

Session 4: Treatment

EHA Library, Faculty / Presenters, 4171851

Oral Abstract Session 2

EHA Library, Faculty / Presenters, 4171850

Session 3: Special situations

EHA Library, Faculty / Presenters, 4171849

Keynote: Complex karyotype in sAML

EHA Library, Faculty / Presenters, 4171848

AbbVie Satellite Symposium: Therapeutic Strategies and Novel Insights in Secondary AML: Sharing Expert Knowledge

EHA Library, Faculty / Presenters, 4171847

Breakout B: Exploring the multifactorial events of AML transformation

EHA Library, Faculty / Presenters, 4171846

Breakout A: Drugs and diseases in th-related AML

EHA Library, Faculty / Presenters, 4171845

Oral Abstracts Session 1

EHA Library, Faculty / Presenters, 4171844

Session 1: Susceptibility and mechanisms of secondary leukemogenesis

EHA Library, Faculty / Presenters, 4171843

Keynote: Classification and epidemiology of secondary and therapy-related leukemias

EHA Library, Faculty / Presenters, 4171842

Opening & Welcome

EHA Library, Faculty / Presenters, 4171841

Individualized treatment in early relapse for patients with relapsed/refractory multiple myeloma (MM)

EHA Library, Menarini Stemline, 4144097

Managing a Rare Disease: Focus on Paroxysmal Nocturnal Haemoglobinuria (PNH) and Biosimilars

EHA Library, Amgen, 4144096

Paving the Future of Relapsed/Refractory Multiple Myeloma Treatment with Bispecific Antibodies

EHA Library, Regeneron, 4144095

Outcomes and experience: Keeping the patient at the centre of the haemoglobinopathy treatment journey

EHA Library, Vertex Pharmaceuticals, 4144094

Individual journeys: Optimising treatment approaches in chronic lymphocytic leukaemia (CLL)

EHA Library, Johnson & Johnson, 4144093

How I treat rare leukemias: implications of recent advances in blastic plasmacytoid dendritic cell neoplasm (BPDCN)

EHA Library, Menarini Stemline, 4144092

Untangling Complex Rare Hematologic Disorders: Paroxysmal Nocturnal Hemoglobinuria (PNH) and Light Chain Amyloidosis (AL)

EHA Library, Alexion AstraZeneca Rare Disease, 4144091

An interactive journey through treatment selection in relapsed/refractory multiple myeloma (RRMM)

EHA Library, Johnson & Johnson, 4144090

Unravelling the mystery of treatment selection in newly-diagnosed multiple myeloma (NDMM)

EHA Library, Johnson & Johnson, 4144089

FIBRINOLYSIS AND FIBRIN STRUCTURE IN VIVO AND EX VIVO: INSIGHTS INTO NEUTROPHIL EXTRACELLULAR TRAPS

EHA Library, Nikolett Wohner, 422432

COMPARATIVE SAFETY AND EFFECTIVENESS OF APIXABAN VS WARFARIN AND RIVAROXABAN VS WARFARIN IN PATIENTS WITH VENOUS THROMBOEMBOLISM IN FINLAND, NORWAY AND SWEDEN

EHA Library, Waleed Ghanima, 422431

SUPERIOR SELECTIVITY OF CS585 TO THE PROSTACYCLIN RECEPTOR TRANSLATES TO A NEW VIABLE TARGET FOR PREVENTION OF THROMBOSIS

EHA Library, Livia Stanger, 422430

LOW-MOLECULAR-WEIGHT HEPARIN DOES NOT PREVENT VENOUS THROMBOEMBOLISM IN ADULTS WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA; PROSPECTIVE SIDE-STUDY OF THE HOVON-100 TRIAL

EHA Library, Mandy Lauw, 422429

MOLECULAR PROFILING FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA: INSIGHTS FROM A VENERABLE DIAGNOSTIC CENTER

EHA Library, Catarina Silva Pinto, 422428

DYNAMIC STIMULATION PROMOTES FUNCTIONAL TISSUE-LIKE ORGANISATION OF A 3D HUMAN LYMPHOID MICROENVIRONMENT MODEL AND ALLOWS TO STUDY CLL CELLS TRAFFICKING IN VITRO

EHA Library, Dafne Barozzi, 420713

EARLY DETECTION OF CLASSIC HODGKIN LYMPHOMA RELAPSE USING ROUTINE SERUM TARC MEASUREMENTS DURING FOLLOW-UP

EHA Library, Sophie Teesink, 419181

SINGLE CELL MULTIOMICS IDENTIFIES ABERRANT COMMUNICATION BETWEEN DENDRITIC CELLS AND LEUKAEMIA STEM CELLS AS A THERAPEUTICALLY TARGETABLE AXIS IN JUVENILE MYELOMONOCYTIC LEUKAEMIA

EHA Library, Eleni Louka, 419094

ADVANCING EARLY DETECTION AND IMPROVED TARGETED THERAPY IN MYELOPROLIFERATIVE NEOPLASMS: INSIGHTS FROM MULTIMODAL IMAGING AND NANOPARTICLE-MEDIATED DRUG DELIVERY

EHA Library, Julian Baumeister, 419093

TAGRAXOFUSP EXHIBITS ANTITUMORAL ACTIVITY IN PRECLINICAL MODELS OF MYELOFIBROSIS AND ENHANCES ANTILEUKEMIC ACTIVITY OF JAK INHIBITORS

EHA Library, Vittoria Nicolis di Robilant, 419092

UMBILICAL CORD MESENCHYMAL STROMAL CELLS AMELIORATE MYELOFIBROSIS IN VIVO.

EHA Library, Chien-Chin Lin, 419091

THE ATYPICAL CHEMOKINE RECEPTOR CCRL2 IS UPREGULATED AND PROMOTES INTERFERON-GAMMA SIGNALING IN ADVANCED MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Theodora Chatzilygeroudi, 419090

EFFICACY OF INCA033989 IN CHRONIC AND ADVANCED FORMS OF CALRDEL52 AND CALRINS5 MYELOPROLIFERATIVE NEOPLASMS (MPN) MODELS

EHA Library, Isabelle Plo, 419089

THE EFFECT OF METHYLATION ON THE LET-7-BCL-XL-BCL2 AXIS AND THE POTENTIAL USE OF BH3 MIMETIC DRUGS IN HISTIOCYTIC NEOPLASMS

EHA Library, Oshrat Hershkovitz-Rokah, 419088

DEVELOPMENT AND IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM EARLY WARNING INFORMATION SYSTEM FOR HOSPITALIZED PATIENTS WITH HEMATOLOGICAL MALIGNANT TUMOR

EHA Library, Liu Tingting, 422433

ACCESS TO SPECIALIZED PALLIATIVE CARE AND HEALTH CARE UTILISATION IN THE LAST MONTH OF LIFE – THE STOCKHOLM EXPERIENCE

EHA Library, Lena von Bahr, 422434

ATTITUDES TO PARTICIPATING IN CLINICAL TRIALS VARY BETWEEN DISTINCT GROUPS OF PEOPLE WITH SICKLE CELL DISEASE: GLOBAL FINDINGS FROM THE LISTEN SURVEY

EHA Library, John James, 422435

MACHINE LEARNING TO TRANSFORM IRON DEFICIENCY SCREENING: FROM RUSTY TOOLS TO CUTTING-EDGE SOLUTIONS

EHA Library, Daniel Kreuter, 422436

ZANUBRUTINIB VS. ACALABRUTINIB IN B-CELL MALIGNANCIES: AN ADVERSE EVENT-BASED ECONOMIC ANALYSIS

EHA Library, Talha Munir, 422437

THE COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS SECOND-LINE THERAPY IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN SWEDEN

EHA Library, Viktor Hedlof Kanje, 422438

EPITOPE BASE EDITING IN HAEMATOPOIETIC CELLS OVERCOMES THE OFF-TARGET EFFECTS OF T-ALL BITARGETED IMMUNOTHERAPY

EHA Library, Guoling Wang, 422439

ULTRASENSITIVE BIOSENSOR FOR NONINVASIVE DIAGNOSIS OF T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Ting Wang, 422440

A NOVEL SINGLE-CELL MEASURABLE RESIDUAL DISEASE (SCMRD) ASSAY FOR SIMULTANEOUS DNA MUTATION AND SURFACE IMMUNOPHENOTYPE PROFILING

EHA Library, Gema Fuerte, 422441

WHOLE-GENOME AND -TRANSCRIPTOME SEQUENCING AS A COMPREHENSIVE PRECISION DIAGNOSTIC TEST IN ACUTE MYELOID LEUKEMIA – A REPORT FROM THE NATIONAL INITIATIVE GENOMIC MEDICINE SWEDEN

EHA Library, Anna Staffas, 422442

PREVIOUS-TRANSPLANT OR NEW-MATCH DONOR CD5 CAR T CELLS IN PEDIATRIC AND ADULT RELAPSED/REFRACTORY T-ALL: FIRST-IN-HUMAN, PHASE 1 STUDY

EHA Library, Jing Pan, 422443

TARGETING EXHAUSTED CYTOTOXIC T CELLS BY CTLA-4 BLOCKADE PROMOTES ELIMINATION OF NEOPLASTIC CELLS IN HUMAN MYELOFIBROSIS XENOGRAFTS

EHA Library, Lara Tavernari, 419087